Intravesical valrubicin in the treatment of carcinoma in situ of the bladder

By Steinberg GD   Kuznetsov DD   O’Connor RC   Alsikafi NF  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 6, 2001-06 ,pp. : 1009-1013

Informa Healthcare

Access to resources Recommend Favorite

Apaziquone as an intravesical therapeutic agent for urothelial non-muscle-invasive bladder cancer

By Yutkin Vladimir   Chin Joseph  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 2, 2012-02 ,pp. : 251-260

Informa Healthcare

Access to resources Recommend Favorite

Cathepsin L is Associated with Proliferation and Clinical Outcome of Urothelial Carcinoma of the Bladder

By Yan J-A   Xiao H   Ji H-X   Shen W-H   Zhou Z-S   Song B   Chen Z-W   Li W-B  

The Journal of International Medical Research, Vol. 38, Iss. 6, 2010-11 ,pp. : 1913-1922

Field House Publishing

Access to resources Recommend Favorite

Treatment options for basal cell carcinoma

By  

Inpharma, Vol. 1, Iss. 1408, 2003-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Treatment Options for Merkel Cell Carcinoma

By Beenken Samuel W.   Urist Marshall M.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 2, Iss. 1, 2004-01 ,pp. : 89-92

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite